Larvol Delta - Atossa-Therapeutics-Announces-Receipt-of-FDA-Safe-to-Proceed-Letter-for-Treatment-of-an-Ovarian-Cancer-Patient-with-Oral-Endoxifen-Under-Expanded-Access-Pathway

endoxifen - Atossa Therap

https://www.globenewswire.com/news-release/2021/03/11/2191501/0/en/Atossa-Therapeutics-Announces-Receipt-of-FDA-Safe-to-Proceed-Letter-for-Treatment-of-an-Ovarian-Cancer-Patient-with-Oral-Endoxifen-Under-Expanded-Access-Pathway.html

Mar 11, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next